FISHER ANTHONY
No ORCID on file
· 48 papers in corpus
· active 2004
Frequent coauthors
- IQBAL Khurshid 48
- WATTS PETER 48
2004
The invention provides a composition for a nasal administration that includes leuprolide and one bioadhesive material that is chitosan. Methods of administration of leuprolide to a mammal suffering from a leuprolide modulated condition, suc…
2004
The invention provides a composition for a nasal administration that includes leuprolide and one bioadhesive material that is chitosan. Methods of administration of leuprolide to a mammal suffering from a leuprolide modulated condition, suc…
2004
The invention provides a composition for a nasal administration that includes leuprolide and one bioadhesive material that is chitosan. Methods of administration of leuprolide to a mammal suffering from a leuprolide modulated condition, suc…
2004
The invention provides a composition for a nasal administration that includes leuprolide and one bioadhesive material that is chitosan. Methods of administration of leuprolide to a mammal suffering from a leuprolide modulated condition, suc…
2004
The invention provides a composition for a nasal administration that includes leuprolide and one bioadhesive material that is chitosan. Methods of administration of leuprolide to a mammal suffering from a leuprolide modulated condition, suc…
2004
The invention provides a composition for a nasal administration that includes leuprolide and one bioadhesive material that is chitosan. Methods of administration of leuprolide to a mammal suffering from a leuprolide modulated condition, suc…
2004
The invention provides a composition for a nasal administration that includes leuprolide and one bioadhesive material that is chitosan. Methods of administration of leuprolide to a mammal suffering from a leuprolide modulated condition, suc…
2004
The invention provides a composition for a nasal administration that includes leuprolide and one bioadhesive material that is chitosan. Methods of administration of leuprolide to a mammal suffering from a leuprolide modulated condition, suc…
2004
The invention provides a composition for a nasal administration that includes leuprolide and one bioadhesive material that is chitosan. Methods of administration of leuprolide to a mammal suffering from a leuprolide modulated condition, suc…
2004
The invention provides a composition for a nasal administration that includes leuprolide and one bioadhesive material that is chitosan. Methods of administration of leuprolide to a mammal suffering from a leuprolide modulated condition, suc…
2004
The invention provides a composition for a nasal administration that includes leuprolide and one bioadhesive material that is chitosan. Methods of administration of leuprolide to a mammal suffering from a leuprolide modulated condition, suc…
2004
The invention provides a composition for a nasal administration that includes leuprolide and one bioadhesive material that is chitosan. Methods of administration of leuprolide to a mammal suffering from a leuprolide modulated condition, suc…
2004
The invention provides a composition for a nasal administration that includes leuprolide and one bioadhesive material that is chitosan. Methods of administration of leuprolide to a mammal suffering from a leuprolide modulated condition, suc…
2004
The invention provides a composition for a nasal administration that includes leuprolide and one bioadhesive material that is chitosan. Methods of administration of leuprolide to a mammal suffering from a leuprolide modulated condition, suc…
2004
The invention provides a composition for a nasal administration that includes leuprolide and one bioadhesive material that is chitosan. Methods of administration of leuprolide to a mammal suffering from a leuprolide modulated condition, suc…
2004
The invention provides a composition for a nasal administration that includes leuprolide and one bioadhesive material that is chitosan. Methods of administration of leuprolide to a mammal suffering from a leuprolide modulated condition, suc…
2004
The invention provides a composition for a nasal administration that include s leuprolide and one bioadhesive material that is chitosan. Methods of administration of leuprolide to a mammal suffering from a leuprolide modulat ed condition, s…
2004
The invention provides a composition for a nasal administration that include s leuprolide and one bioadhesive material that is chitosan. Methods of administration of leuprolide to a mammal suffering from a leuprolide modulat ed condition, s…
2004
The invention provides a composition for a nasal administration that includes leuprolide and one bioadhesive material that is chitosan. Methods of administration of leuprolide to a mammal suffering from a leuprolide modulated condition, suc…
2004
The invention provides a composition for a nasal administration that includes leuprolide and one bioadhesive material that is chitosan. Methods of administration of leuprolide to a mammal suffering from a leuprolide modulated condition, suc…
2004
The invention provides a composition for a nasal administration that includes leuprolide and one bioadhesive material that is chitosan. Methods of administration of leuprolide to a mammal suffering from a leuprolide modulated condition, suc…
2004
The invention provides a composition for a nasal administration that include s leuprolide and one bioadhesive material that is chitosan. Methods of administration of leuprolide to a mammal suffering from a leuprolide modulat ed condition, s…
2004
The invention provides a composition for a nasal administration that includes leuprolide and one bioadhesive material that is chitosan. Methods of administration of leuprolide to a mammal suffering from a leuprolide modulated condition, suc…
2004
The invention provides a composition for a nasal administration that include s leuprolide and one bioadhesive material that is chitosan. Methods of administration of leuprolide to a mammal suffering from a leuprolide modulat ed condition, s…
2004
The invention provides a composition for a nasal administration that include s leuprolide and one bioadhesive material that is chitosan. Methods of administration of leuprolide to a mammal suffering from a leuprolide modulat ed condition, s…